Therapeutic Newsletters

Focus on Cardiology, Pulmonology, and Blood
NHLBI study: hiv-infected men at increased risk for heart disease. The buildup of soft plaque in arteries that nourish the heart is more common and extensive in HIV-infected men than HIV-uninfected men, independent of established cardiovascular disease risk factors, according to a new study. The findings suggest that HIV-infected men are at greater risk for a heart attack than their HIV-uninfected peers... Read More

Focus on Nephrology, Endorinology, Metabolism, and Gastroenterology
NIDDK leads collaborative efforts to catalyze creation of artificial pancreas. Both type 1 and type 2 diabetes cause the levels of glucose in the blood to rise above a normal, healthy range. When blood glucose levels are not well controlled, a person with diabetes is at much greater risk for developing devastating health complications, including blindness, kidney disease and kidney failure, nerve problems, and cardiovascular dis-ease... Read More

Focus on Neurology and CNS
NINDS study on key parkinson’s gene finds possible new target to monitor disease. Scientists may have discovered how the most common genetic cause of Parkinson’s disease de-stroys brain cells and devastates many patients worldwide. The results of the study, partially funded by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS), may help scientists develop new therapies... Read More

Focus on Oncology
NCI study finds regular asprin use may reduce ovarian cancer risk. Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI). However, further research is needed before clinical recommendations can be made... Read More

Focus on Rheumatology, Inflammation, Anesthesia, and Pain
NIAMS funded arthritis analysis supports drug discovery. An international research team identified 42 new areas in the human genome associated with rheumatoid arthritis—and found that many are al-ready the targets of drugs approved for other conditions. The findings hint at new treatment approaches for the disease... Read More

Focus on Allergy, Infectious Disease, and Antiviral
NIAID funds influenza research and surveillance network. Influenza scientists at five sites in the United States are to receive funding from the National Institute of Allergy and Infectious Diseases (NIAID) to collaborate with investigators around the globe in a network designed to advance understanding of influenza viruses and how they cause disease... Read More